LeMaitre Vascular Inc (NASDAQ:LMAT)
| 54.55 Delayed Data As of Sep 29 |  -0.60 / -1.09%Today’s Change | 41.78 Today|||52-Week Range 68.67 | +18.54% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $1.2B |
Company Description
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
Contact Information
LeMaitre Vascular, Inc. 63 Second Avenue Burlington Massachusetts 01803 |
Employees
Shareholders
| Mutual fund holders | 47.68% |
| Other institutional | 38.47% |
| Individual stakeholders | 13.64% |
Top Executives
| George W. LeMaitre | Chairman & Chief Executive Officer |
| David B. Roberts | President & Director |
| Trent G. Kamke | Senior Vice President-Operations |
| Joseph P. Pellegrino | Chief Financial Officer, Secretary & Director |
| Jonathan W. Ngau | Vice President-Information Technology |
